David P. Bonita, Director, 10% Owner at Prelude Therapeutics Inc (PRLD), bought 1,739,130 shares at $5.75 ($10.0M) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Open-market purchase of $10.0M PRLD by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.75 | 869,565 | $5.0M | 50.0% |
| 2 | $5.75 | 869,565 | $5.0M | 50.0% |
| Total | $5.75 avg | 1,739,130 | $10.0M | 100% |
| Filing → |
| TCDA | SELL | 2022-11-25 | $3.2M | — | Filing → |
| THRD | BUY | 2022-09-21 | $5.1M | — | Filing → |
| IKNA | BUY | 2022-06-24 | $1.1M | — | Filing → |